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With 1.6 million new cases diagnosed each year and 1.3 million deaths, lung cancer is the leading cause of cancer-related deaths 
worldwide and represents a pressing health issue that generates signifi-
cant personal and social costs (1). 
Patients with lung cancer often experience greater fatiguability, a 
reduction in exercise tolerance, muscle weakness and compromised 
quality of life (QoL) as a direct consequence of their disease or as an 
indirect consequence of their cancer therapy (2-4). For individuals 
with localized non-small cell lung cancer (NSCLC), lung resection 
surgery (LRS) offers the best chance of cure. Although survival rates 
are improved following the surgery, morbidity and mortality rates 
resulting from postoperative cardiopulmonary complications remain 
considerable. Moreover, because of the link between low exercise cap-
acity and cardiopulmonary complications following LRS (5-7), exer-
cise tolerance is an important element in the decision-making process 
regarding the feasibility of lung cancer resection, especially in patients 
with low aerobic capacity.  
Although the effectiveness of exercise-based rehabilitation pro-
grams are well recognized to improve exercise capacity, muscle 
strength and QoL for patients with various pulmonary disorders (8,9), 
the role of this intervention in an oncology setting is less well defined. 
However, there is emerging literature suggesting that exercise-based 
rehabilitation may improve oxygen uptake, physical fitness, muscle 
function and QoL in cancer patients (10,11). In lung cancer patients, 
exercise-based rehabilitation has received increased attention (12-15), 
with some promising studies demonstrating that it is possible to 
improve exercise performance and symptoms without increasing the 
risk of promoting cancer progression (12,13,16). 
Consequently, the implementation of a preoperative exercise-
based rehabilitation program focused on improving exercise capacity 
and muscle function could have significant positive outcomes in 
patients with lung cancer, notably by reducing postoperative mortality 
and morbidity (7). In this regard, it seems clinically relevant to use the 
preoperative waiting period to increase the exercise tolerance of 
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BaCkgRound: Patients with lung cancer often experience a reduction 
in exercise tolerance, muscle weakness and decreased quality of life. 
Although the effectiveness of pulmonary rehabilitation programs is well 
recognized in other forms of cancers and in many pulmonary diseases, few 
researchers have studied its impact in patients with lung cancer, particu-
larly in those awaiting lung resection surgery (LRS). 
oBJeCtiVeS: To investigate the feasibility of a short, home-based exer-
cise training program (HBETP) with patients under investigation for non-
small cell lung cancer and potential candidates for LRS, and to determine 
the effectiveness of this program on exercise tolerance, skeletal muscle 
strength and quality of life. 
MethodS: Sixteen patients with lung cancer awaiting LRS participated 
in a four-week HBETP including moderate aerobic activities (walking and 
cycling) and muscle training performed three times weekly. Before and 
after the intervention, a cardiopulmonary exercise test, a 6 min walk test 
and the assessment of muscle strength and quality of life were performed. 
ReSultS: Thirteen patients completed the four-week HBETP and all 
the patients completed >75% of the prescribed exercise sessions. The dura-
tion of the cycle endurance test (264±79 s versus 421±241 s; P<0.05) and 
the 6 min walk test distance (540±98 m versus 568±101 m; P<0.05) were 
significantly improved. Moreover, the strength of the deltoid, triceps and 
hamstrings were significantly improved (∆ post-pre training 1.82±2.83 kg, 
1.32±1.75 kg and 3.41±3.7 kg; P<0.05, respectively). 
ConCluSion: In patients with lung cancer awaiting LRS, HBETP was 
feasible and improved exercise tolerance and muscle strength. This may be 
clinically relevant because poor exercise capacity and muscle weakness are 
predictors of postoperative complications. 
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la faisabilité et l’efficacité d’un programme 
d’exercices à domicile avant une résection 
pulmonaire 
hiStoRiQue : Les patients atteints d’un cancer du poumon sont sou-
vent moins tolérants à l’exercice et présentent souvent une faiblesse mus-
culaire et une diminution de leur qualité de vie. Même si l’efficacité des 
programmes de réadaptation pulmonaire est reconnue pour d’autres formes 
de cancers et de nombreuses maladies pulmonaires, peu de chercheurs en 
ont étudié les répercussions en cas de cancer du poumon, notamment chez 
les personnes en attente d’une résection pulmonaire (RP).
oBJeCtiFS : Examiner la faisabilité d’un court programme d’exercices à 
domicile (CPED) chez des patients en cours d’examens diagnostiques d’un 
cancer pulmonaire non à petites cellules qui étaient des candidats poten-
tiels à une RP, et déterminer l’efficacité de ces programmes sur la tolérance 
à l’exercice, la force musculaire squelettique et la qualité de vie.
MÉthodologie : Seize patients atteints d’un cancer du poumon en 
attente d’une RP ont participé à un CPED de quatre semaines comportant 
des activités aérobiques modérées (marche et vélo) et un entraînement 
musculaire à une fréquence de trois fois par semaine. Avant et après 
l’intervention, les patients ont subi une épreuve d’effort cardiorespiratoire, 
une épreuve d’effort de 6 minutes et une évaluation de la force musculaire 
et de la qualité de vie.
RÉSultatS : Treize patients ont effectué le CPED de quatre semaines et 
tous les patients ont effectué au moins 75 % des séances d’exercices prescrites. 
La durée du cycle de leur épreuve d’endurance (264±79 s par rapport à 
421±241 s; P<0,05) et la distance de leur épreuve d’effort de 6 minutes 
(540±98 m par rapport à 568±101 m; P<0,05) s’amélioraient considérable-
ment, de même que la force de leurs deltoïdes, de leurs triceps et de leurs 
ischiojambiers (∆ après-avant l’entraînement 1,82±2,83 kg, 1,32±1,75 kg 
et 3,41±3,7 kg; P<0,05, respectivement). 
ConCluSion : Chez les patients atteints d’un cancer du poumon en 
attente d’une RP, le CPED était faisable et améliorait la tolérance à 
l’exercice et la force musculaire. Ce peut être pertinent sur le plan clinique, 
car une capacité à l’exercice médiocre et une faiblesse musculaire sont des 
prédicteurs de complications postopératoires.
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patients with lung cancer. However, implementation of exercise-based 
rehabilitation in a supervised setting would be difficult, due to a lack 
of accessibility of resources and also because the preoperative period 
itself is a very stressful and busy time for the patients, a context that 
may impact on their willingness to participate in such a program 
(16,17).  
The effectiveness and safety of a home-based exercise training 
intervention has already been demonstrated in patients with severe 
emphysema awaiting lung volume reduction surgery (18). Those 
results were recently confirmed in a randomized multicentre clinical 
trial on home-based pulmonary rehabilitation in chronic obstructive 
pulmonary disease (COPD) that was conducted in 10 participating 
centres across Canada (19). However, its implementation and efficacy 
in patients with lung cancer needs to be addressed.  
Therefore, we aimed to prospectively examine the feasibility of a 
short (four week), home-based exercise training program (HBETP) 
with patients under investigation for NSCLC and potential candidates 
for LRS, and to determine the effectiveness of this program on exercise 
capacity, muscle strength and QoL.
MethodS
Study design
The present analysis was a nonrandomized interventional study con-
ducted at the Institut universitaire de cardiologie et de pneumologie de 
Québec (IUCPQ) (Sainte-Foy, Quebec). The research protocol was 
approved by the institutional ethics committee. All of the participants 
provided written informed consent before study enrollment. 
Potentially eligible patients (men or women, between 45 and 
80 years of age, under investigation for NSCLC) were recruited 
from the Clinique spécialisée en pneumologie of IUCPQ. Exclusion cri-
teria were as follows: oxygen-pulsed saturation (SpO2) <80% during 
the cardiopulmonary exercise test; contraindications to exercise test-
ing (per American Thoracic Society [ATS]/American College of 
Chest Physicians Exercise Testing Guidelines [20]); a history of signifi-
cant cardiovascular disease, hypertension, diabetes or musculoskeletal 
concerns that might limit the ability of these subjects to perform 
active exercises; and severe psychiatric illness compromising adher-
ence to training rehabilitation. 
A complete assessment of pulmonary function, exercise capacity, 
muscle strength and QoL was performed before and after completion 
of the four-week HBETP. The full assessment was performed in one 
day and all tests were administered in the same order pre- and post-
HBETP. Care was taken to allow a 2 h rest period between incremental 
and constant cycling tests, and a 20 min rest period between the two 
6-min walk tests (6MWTs). 
assessments
anthropometric and pulmonary measurements: Weight and height 
were measured to determine body mass index. Standard pulmonary 
function tests including spirometry, lung volumes and carbon monox-
ide diffusion capacity, were performed for all subjects according to 
previously described guidelines (21) and compared with predicted ref-
erence values (22,23).
exercise capacity: Exercise capacity was assessed using the following 
exercise tests: 
Incremental cycling exercise test: Peak exercise capacity and oxygen 
consumption were determined during incremental cycle ergometry 
with 12-lead electrocardiogram monitoring (Cardiosoft, Corina, 
USA) as originally described by Jones et al (3) and following the ATS 
guidelines (20). Briefly, the tests were performed on an electronically 
braked cycle ergometer (Quinton Corival 400; A-H Robins, USA) 
with breath-by-breath expired gas analysis (Sensor Medics, Vmax 
Legacy, USA) to monitor ventilation, oxygen consumption (V∙ O2), car-
bon dioxide output and respiratory exchange ratio. After 3 min of rest, 
participants began unloaded cycling for 1 min. Each subsequent minute, 
workload was increased by 10 W to 20 W until a symptom limitation 
was achieved. During exercise, heart rate (ECG Cardiosoft, Corina, 
USA) and SpO2 (OSM2 Hexoximeter, Radiometer, Denmark) were 
monitored continuously, whereas blood pressure was measured every 
2 min (Quinton 410, A-H Robins Cie, USA). Dyspnea and leg 
fatigue were evaluated every 2 min using a modified Borg scale for 
perceived exertion (24). 
Constant workrate cycle exercise: The constant workrate cycle 
exercise test was monitored similarly to the maximal exercise test. 
After 1 min of unloaded cycling, patients were asked to pedal to 
exhaustion at 80% of the peak workload determined during the incre-
mental test. Heart rate, dyspnea Borg score and oxygen saturation were 
monitored. The endurance time was defined as the duration of the test 
excluding the 1 min warm-up period.
6MWT: According to the ATS guidelines (25), the 6MWT was con-
ducted in an enclosed corridor on a flat, 30 m long course between two 
cones. Patients were instructed to cover the longest distance possible 
in 6 min with or without pause. During the test, only standardized 
encouragement was given to the patient (25). The test was performed 
twice and the greater distance was recorded.
Muscle strength: Quadriceps strength of the dominant leg was 
assessed by measuring maximum voluntary contraction. Subjects were 
seated in a recumbent chair (N-K 330 Exercise Table; N-K Products, 
USA) with 90° knee flexion and the ankle attached to a strain gauge 
(Hewlett-Packard, USA). Maximum voluntary contraction of the 
dominant biceps, triceps, deltoid and hamstring were measured using a 
hand-held dynamometer (Microfet, Hoggan Inc, USA) using the 
method described and validated by Andrews et al (26). Finally, max-
imal prehension strength was assessed using a hydraulic dynamometer 
(Jamar, Lafayette Instrumet Company, USA). Muscle strength assess-
ment was performed during the rest period between cycling tests. 
Reported values for maximum voluntary contraction of all muscles are 
the mean of the two strongest contractions and strength is reported in 
kilograms.
QoL: QoL was assessed using three standard questionnaires described 
and validated for patients with lung cancer. The 36-item Short-Form 
Health Survey (SF-36) was selected as a generic questionnaire to assess 
QoL for its ease of administration and because it has comparative nor-
mative values (27). A French-Canadian version of the SF-36 is cur-
rently available and was previously validated (27). Cancer-related 
QoL was assessed using the self-reported European Organization for 
Research and Treatment of Cancer Quality of Life Questionnaire 
(EORTC QLQ-30) including the lung cancer-specific questionnaire 
QLQ-LC13 (28,29). This questionnaire was developed and validated 
for cancer patients. It includes 30 items divided into functional, symp-
tom and health-related subscales. Finally, the French Canadian ver-
sion of the Hospital Anxiety and Depression Scale (HADS) was used 
to identify patients with anxiety disorders or depression (30). It has 
14 questions divided into an anxiety subscale (HADS-A) and a 
depression subscale (HADS-D). Questionaires were systematically 
completed at the beginning of the evaluation day.
heBtP
Following the initial assessment, participants began a four-week exercise-
training program. This was a self-monitored and minimally supervised 
home-exercise program. Exercise training modalities and intensity 
were adapted to patient’s individual condition. It included aerobic and 
strength exercises three to five times per week for four weeks. Aerobic 
training was performed on a loaned portable ergocycle on which resist-
ance could be manually adjusted. The target intensity corresponded to 
60% to 80% of the peak workload achieved during the incremental 
cycling exercise test, aiming for a cumulative time of 30 min. Patients 
were also instructed to reduce the intensity of training in case of a 
dyspnea Borg score ≥6. Free weights (1 kg to 2 kg) and gravity-resisted 
exercises were used to train the muscle groups of the upper limbs 
(biceps curl, wall push-up, lateral shoulder raise), lower limbs (wall 
squat, hips raise) and abdominal wall (sit up). Ten repetitions of each 
movement were initially performed. The number of repetitions was 
progressively increased, as tolerated, until two sets of 15 repetitions 
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were achieved. Home training periods, training intensity and adverse 
events were noted in a diary. Individual teaching with practice and 
feedback were performed by a kinesiologist before the program to 
ensure complete understanding from participants. Furthermore, weekly 
telephone follow-ups were conducted to ensure patient adherence, to 
adjust the exercise prescription and to follow potential adverse events. 
This strategy was previously used successfully in clinical trials involv-
ing patients with COPD (19) and patients with emphysema in prep-
aration for lung volume reduction surgery (18).
Feasibility outcomes 
To assess the feasibility of the HBETP, recruitment rate, completion 
rate, adherence, adverse events, subjective perception of obstacles, 
and benefits and acceptability were collected and analyzed. Recruitment 
rate was defined as the ratio of the recruited patients to those who 
were eligible. Completion rate was defined as the proportion of partici-
pants who completed all of the intervention from the moment of the 
initial assessment. Adherence was calculated from the ratio of the 
number of completed exercise sessions over the number of prescribed 
sessions (12). In pulmonary rehabilitation programs involving COPD 
patients, the reported adherence rates vary between 74% and 83% 
(31-33). Therefore, a similar adherence rate was anticipated in the 
present population. It was determined a priori that patients who 
attended nine training sessions during the four-week period (75%) 
would be classified as meeting the adherence requirement. In addi-
tion, adverse events were systematically tracked during the weekly 
telephone call. 
Finally, a motivational survey developed by the authors was used to 
describe the subjective perception of obstacles and benefits, and the 
acceptability of the program. The survey also provided an overview of 
which situations may increase or decrease the motivation of the 
patient to perform physical activities and asked questions about per-
ception of physical fitness. Questions such as the following were asked: 
“Overall, how would you rate your current physical condition?”; “How 
were you motivated to engage in the HBETP? ”; “To what extent do 
you think your participation in this HBETP was good for you?” All 
questions were answered on a scale from 1 to 7. A high score generally 
indicates a positive association, except for the obstacles scales in 
which a higher score indicates more perceived obstacles. 
Statistical analysis
Baseline subject characteristics, including demographics, pulmonary 
function, muscle strength and score on all exercise and functional 
tests, were reported using descriptive data (mean ± SD). Isotime was 
defined as the highest equivalent duration reached pre- and post-
HBETP for the cycle endurance test. Pre- and post-training compari-
sons were made using a paired t test; P<0.05 was considered to be 
statistically significant. The data were analyzed using SAS version 9.2 
(Service Pack 4, SAS Institute Inc, USA).
ReSultS
Feasibility outcomes
A flow chart of the study is presented in Figure 1. From May 2009 to 
November 2010, 72 patients were initially identified as potentially 
eligible. After detailed review of medical history, 52 patients were 
excluded because they were ineligible (n=32) and 20 patients declined 
to participate. The main reasons for nonconsent were lack of time 
(n=6); not specified (n=6); lack of interest about engaging in a 
research project (n=5); or high level of anxiety (n=3). 
Finally, 20 patients consented to participate over the 40 who were 
truly eligible, yielding a recruitment rate of 50%. Among those who 
consented, 16 completed the baseline evaluation. Four patients were 
excluded before the baseline evaluation due to scheduled surgery 
within one week of consent (n=3) or clinical deterioration (n=1). 
Three patients failed to complete the rehabilitation program due to 
clinical deterioration (n=2) or psychological distress (n=1). Thus, 
13 patients completed all the HBRTP, yielding a completion rate of 
81%. They performed a mean of 15±5 aerobic exercise sessions and a 
mean of 10±4 muscle strengthening sessions of the 12 prescribed. All 
of the participants reached the adherence goal of 75% (nine sessions) 
with a mean adherence of 125% and 83% for the aerobic and strength 
prescriptions, respectively. Finally, no adverse events were reported by 
patients during telephone follow-up. 
Participant characteristics
The baseline characteristics for the 13 patients who completed the 
four-week HBETP are presented in Table 1. Patients who completed 
the HBETP had a relatively preserved exercise capacity with a mean 
percentage of predicted peak V∙ O2 of 107%. Some patients had one or 
more of the following comorbidities: COPD (n=5), arterial hyperten-
sion (n=5), dyslipidemia (n=3), type 2 diabetes (n=2) and anxiety 
(n=2). No significant difference for physiological or psychological 
characteristics were observed between patients who completed the 
program and those who did not.
Physiological effects of training
Physiological data before and after completion of the HBETP are pre-
sented in Table 2. Compared with pre-HBETP, the post-HBETP peak 
V∙ O2, peak workload and pulmonary function were not significantly 
different. Constant workrate cycle exercise duration significantly 
improved by 60% (157±195 s), with seven patients increasing their 
endurance time by more than 100 s (Figure 2, panels A and B). The 
6MWT distance improved by 28±29 m (540±98 prerehabilitation 
versus 568±101 postrehabilitation; P<0.05), with seven patients 
increasing their 6MWT distance by more than 26 m (Figure 2, panels 
C and D). Compared with pre-HBETP, isotime V∙ O2, carbon dioxide 
output, ventilation and respiratory exchange ratio were reduced after 
the HBETP (Figure 3). 
Strength of the deltoid, triceps and hamstring muscles increased sig-
nificantly with training by 1.82±2.83 kg, 1.32±1.75 kg and 3.41±3.7 kg, 
respectively (P<0.05). This corresponded to a strength improvement 
of 18±31%, 14±25% and 27±40%, respectively (P<0.05). In contrast, 
changes in hand grip, biceps and quadriceps strength with training 
were not statistically significant.
Motivational survey
After the HBETP, perceived physical fitness improved significantly 
(3.38±1.26 pre-HBETP versus 4.69±0.95 post-HBETP; P<0.05). The 
most commonly perceived benefits reported by the patients were: 
helped to start performing physical activities (n=6); improved dyspnea 
(n=5); improved strength (n=3); and having more energy (n=3). The 
most important obstacle was the lack of time to perform the program 
and the difficulties in integrating it into an already busy schedule of 
several medical appointments. Nevertheless, patients believed that 
Figure 1) Flow diagram of the study
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the intervention was relevant for individuals with lung cancer, that 
they were willing to encourage a friend with cancer to engage in such 
a program and that they were globally very satisfied with their partici-
pation (mean 5.85, 6.08 and 6.07 on the 0 to 7 scale, respectively).
Qol
The impact of the HBETP on health-related QoL is presented in 
Table 3. With the exception of an improvement in the depression 
scale of the HADS, there were no significant changes for any measure 
of QoL after the intervention. 
diSCuSSion
To our knowledge, the present investigation was the first to examine 
the feasibility and potential benefit of a short (four weeks) HBETP 
with patients under investigation for NSCLC and potential candidates 
for LRS. The main finding of the present study was that a short, mod-
erate intensity, HBETP was feasible, safe and well tolerated in this 
context. In addition, participation in such a program produced physio-
logical effects, including improved cycling endurance, walk distance 
and muscle strength.
Although the recruitment rate was low, the completion rate and 
adherence to the program were acceptable. In other studies, comple-
tion rates for exercise intervention programs varied widely. For 
example, Temel and al (16) reported a completion rate of 44% in 
patients with advanced NSCLC. There are several possible 
TaBlE 2
Physiological response at peak incremental exercise and 
at the end of constant workrate exercise before and after 
the four-week home-based exercise training program 
Variable
Rehabilitation
PPre Post
Incremental cycling exercise
   V∙ O2peak, mL/kg/min 21.6±7.8 23.3±7.5 NS
   V∙ O2peak, % predicted 107±23 103±25 NS
   V∙ O2peak, L/min 1.63±0.64 1.75±0.71 NS
   Peak heart rate, beats/min 144±26 149±24 NS
   Peak workrate, W 110±53 118±50 NS
   V∙ Epeak, L/min 66.1±27.4 68.0±20.3 NS
   RRpeak, breath/min 39±11 42±11 NS
   RERpeak 1.22±0.11 1.23±0.10 NS
   SpO2peak, % 95±5 96±4 NS
Constant workrate cycling exercise
   Duration, s 264±79 421±241 <0.05
   Workrate, W 88±42 88±42 NS
   V∙ O2, mL/kg/min 21.4±7.3 21.6±7.2 NS
   Heart rate, beats/min 144±26 146±29 NS
   V∙ E, L/min 60.9±23.8 61.7±25.2 NS
   RR, breaths/min 38±11 41±11 NS
   RER 1.18±0.07 1.08±0.10 <0.05
   SpO2, % 95±3 97±3 NS
   Dyspnea Borg score 7±2 7±2 NS
   Leg fatigue Borg score 7±2 7±2 NS
Data presented as mean ± SD unless otherwise indicated. NS Not statistically 
significant; RER Respiratory exchange ratio; RR Respiratory rate; SpO2 Pulse 
oxygen saturation; V∙ E Ventilation; V∙ O2 Oxygen uptake 
Figure 2) Group mean ± SD (panels a and C) and individuals values 
(panels B and d) for the endurance time during the constant workrate 
cycling exercise (panels a and B) and for the 6 min walk distance (panels 
C and d) at the pre- (closed bars) and post- (open bars) rehabilitation 
assessment. *P<0.05
TaBlE 1
Subject characteristics (n=13)
Variable Patients
Age, years 59±9
Sex, male/female, n/n 5/8
Body mass index, kg/m2 27±7
Smoking status, n
   Current 6
   Former 4
   Never smoker 3
V∙ O2 peak, mL/kg/min 22±78
V∙ O2 peak, % predicted 107±23
Pulmonary function
   FEV1, L 2.18±0.87
   FEV1, % predicted 79±21
   Forced expiratory capacity, L 3.33±1.04
   FVC, % predicted 97±19
   FEV1/FVC, % 64±9
   Total lung capacity, L 5.88±1.28
   Total lung capacity, % predicted 102±13
   Residual volume, L 2.45±0.82
   Residual volume, % predicted 117±36
   DLCO, mL/min/mmHg 18.02±7.61
   DLCO, % predicted 80±24
Diagnosis, n
   Adenocarcinoma 9
   Squamous carcinoma 1
   Typical carcinoid tumor 1
   Round pneumonia 1
   Langerhans cell histiocytosis 1
Cancer stage, n
   I 5
   II 4
   III 0
   IV 2
Treatment during rehabilitation, n
   Awaiting surgery 10
   Chemotherapy 1
   Palliative chemotherapy 1
   Palliative radiotherapy + chemotherapy 1
Data presented as mean ± SD unless otherwise indicated. DLCO Diffusion 
capacity of carbon monoxide; FEV1 Forced expiratory volume in 1 s; FVC 
Forced vital capacity; V∙ O2 Oxygen uptake
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explanations for the high completion rate in our study. First, most of 
our patients were young and had early stage lung cancer and, further-
more, as suggested by Temel and al (16), an HBETP may be more 
feasible in this population. Moreover, modalities and intensities of 
training were adapted to the patients’ individual condition and a 
weekly phone follow-up was conducted to reinforce the importance of 
the exercises, to detect problems and to adjust the exercise prescrip-
tion, if necessary. In addition to to this close follow-up, a potential 
selection bias associated with referral patterns by the nurses, pul-
monologists and surgeons may have influenced the results by selecting 
people who were initially more motivated to perform physical activ-
ities. On the other hand, none of the participating patients were 
regularly physically active before the intervention. 
Another important finding was that the HBETP had beneficial 
effects on exercise capacity and muscle strength. The absence of 
improved peak exercise capacity in such a short training program is 
not unexpected because this parameter does not change markedly with 
exercise training (34). We found a statistically and clinically signifi-
cant improvement in the endurance time to constant workrate cycling 
exercise and in the 6MWT distance. The 157 s increase in the endur-
ance time to constant workrate exercise exceeded the 100 s that is 
generally considered to represent a clinically significant outcome for 
this variable (35). Similarly, the gain in the 6MWT distance was 
superior to the minimal important difference for this variable (36). 
The possibility to improve muscle strength before the surgery is of 
clinical interest. Bolliger et al (37) recently reported the frequent 
occurrence of muscle weakness in lung cancer patients and confirmed 
that after lobectomy, much of the limitation in exercise capacity may 
be explained by peripheral muscle function. 
While exercise led to a substantial improvement of physiological 
parameters, no statistically significant or clinically meaningful changes 
in QoL were observed, apart from a reduction in depression score, 
which was statically and clinically reduced postrehabilitation. This 
improvement may be clinically relevant because in cancer patients, 
depression is associated with increased mortality, poorer adherence to 
treatment and increased length of hospitalization after thoracic sur-
gery for malignancy (38,39). Also, for the SF-36, compared with nor-
mative data (40), physical functioning, general health and social 
functioning were all significantly lower in our patients. However, 
Figure 3) Group mean ± SD isotime values during the constant workate 
cycling exercise test for peak oxygen consumption (V∙ O2, panel a); carbon 
dioxide output (V∙ CO2, panel B); respiratory exchange ratio (RER, panel C), 
respiratory rate (RR, panel d), ventilation (V∙  E, panel e), heart rate 
(HR, panel F), dyspnea Borg score (panel g), fatigue Borg score (panel h) 
and V∙  E /maximum voluntary ventilation (MVV) ratio (panel i), pre- 
rehabilitation (pre, closed bars) and postrehabilitation (post, open bars) 
TaBlE 3
Quality of life before and after the four-week home-based 
exercise training program
Rehabilitation
PPre Post
SF-36 domains
   Physical functioning 61.5±23.1 63.9±23.0 NS
   Role physical 67.3±26.4 63.6±24.6 NS
   Bodily pain 69.2±29.0 69.6±17.7 NS
   General health 59.7±19.8 59.3±21.9 NS
   Vitality 57.2±21.2 61.5±16.1 NS
   Social functioning 68.3±26.8 76.0±26.7 NS
   Role emotional 69.9±26.2 69.2±21.4 NS
   Mental health 67.3±21.7 68.9±14.7 NS
QLQ-C30 subscale
   Global health status/QoL 51.3±18.0 54.0±18.2 NS
   Physical functioning 73.3±31.3 73.3±30.6 NS
   Role functioning 69.4±32.4 73.6±30.5 NS
   Emotional functioning 62.5±22.1 65.2±28.0 NS
   Cognitive functioning 66.6±32.6 79.1±25.8 NS
   Social functioning 88.9±16.4 83.3±21.3 NS
   Fatigue 21.3±15.3 26.8±16.0 NS
   Nausea and vomiting 6.9±13.2 2.8±6.5 NS
   Pain 11.1±16.4 11.1±14.8 NS
   Dyspnea 30.5±30.0 30.5±22.3 NS
   Insomnia 22.2±29.6 19.4±22.3 NS
   Appetite loss 13.9±22.3 8.3±20.7 NS
   Constipation 5.6±13.0 11.1±16.4 NS
   Diarrhea 8.3±15.1 2.8±9.6 NS
   Financial difficulties 0±0 2.8±9.6 NS
QLQ-LC13 subscale
   Dyspnea 28.7±20.9 23.1±14.6 NS
   Coughing 41.6±20.9 25.0±20.7 NS
   Haemoptysis 5.6±25.1 2.8±9.6 NS
   Sore mouth 2.8±9.6 0±0 NS
   Dysphagia 11.1±16.4 2.8±9.6 NS
   Peripheral neuropathy 8.3±20.7 11.1±21.7 NS
   Alopecia 11.1±21.7 11.1±21.7 NS
   Pain in chest 5.6±13.0 8.33±20.7 NS
   Pain in arm or shoulder 13.9±26.4 16.7±22.5 NS
   Pain in other parts 16.7±22.5 11.1±16.4 NS
HADS
   Anxiety 8.8±4.2 7.4±3.5 NS
   Depression 5.4±3.6 3.9±2.3 <0.05
Data presented as mean ± SD. HADS Hospital Anxiety and Depression Scale; 
NS Not statistically significant; QLQ-C30 European Organization for Research 
and Treatment of Cancer Quality of Life Questionnaire; QLQ-LC13 Lung 
Cancer-Specific Questionnaire; QoL Quality of life; SF-36 Short-Form 36 
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following the program, social functioning was no longer different from 
normative data but role limitations due to physical problems, role 
limitations due to emotional problems and mental health became dif-
ferent, suggesting that the preoperative period itself may have had an 
impact on QoL. On a positive note, it is possible that without exercise 
training, patients may have experienced a worse decline of their QoL; 
however, in the absence of a control group, it is difficult to draw a 
definitive conclusion. Nevertheless, these findings are consistent with 
the conflicting results in the literature and with the other studies that 
did not find any change in QoL following exercise training in patients 
with lung cancer (41-43). Other studies specially designed to address 
this relevant question need to be conducted. In addition, it could be 
hypothesized that the absence of any educational or group-based ses-
sions in the present study may have impacted the capacity of the 
intervention to improve QoL. Other studies specifically designed to 
address this relevant question need to be conducted. 
Although we found that HBETP was feasible in patients under 
investigation for NSCLC, we acknowledge that only 50% of the pot-
entially eligible candidates agreed to participate in the present study. 
The main reasons for this relatively low recruitment rate included a 
high level of anxiety, lack of interest and lack of time. Nonparticipation 
in this type of intervention could be explained by a variety of barriers 
such as psychological distress (anxiety, depression) or physical symp-
toms (pain, fatigue). The challenge of facing a cancer diagnosis may 
have, by itself, impacted the patients’ willingness to participate in our 
study (16). 
Some methodological aspects of our study warrant consideration. 
First, due to the short period of time between the final diagnosis of 
lung cancer and surgery, we decided a priori to include patients 
immediately when they began their investigation for lung cancer. 
Despite this recruitment strategy, only one patient did not ultimately 
have lung cancer. Thus, we are confident that the data from our study 
can be generalized to a large proportion of patients with lung cancer 
awaiting LRS. The tight schedule of the patients during the preopera-
tive period led to another challenging limitation: the requirement of a 
one-day assessment period. In a perfect setting, the evaluation would 
be performed during two different visits. However, in the present study, 
this design was not possible because of the short period of time 
allowed. However, to minimize bias, all tests were administered in the 
same order in pre- and post-HBETP and a 2 h rest period between 
incremental and constant cycle exercise tests and 20 min between the 
two 6MWT was allowed.
Additionally, the small number of patients who agreed to partici-
pate reduced the statistical power of the study. One message to gain 
from this is that rehabilitative interventions are challenging to imple-
ment in clinical practice. 
From this perspective, it could be hypothesized that due to imple-
mentation difficulties of rehabilitation on a large scale, this modality 
should be primarily considered for compromised patients who are sel-
dom candidates for surgery because of their marginal cardiovascular 
capacity and because of the postoperative cardiopulmonary complica-
tions related to it. Indeed, based on physiological results achieved in 
our study and the available literature, it is reasonable to believe that it 
is possible to sufficiently improve the aerobic capacity of some of these 
patients to place them above the threshold where the risk of complica-
tions are acceptable to consider surgery. In addition, a recent study by 
Bozcuk and Martin (44) found that delaying treatment until 48 days 
after diagnosis did not appear to have any effect on survival. Thus, it 
may be beneficial to use an extended preoperative period to improve 
cardiovascular fitness of some patients with the aim of reducing pos-
toperative complications. However, the present study was not designed 
nor did it have the statistical power to determine whether exercise 
training could lower postoperative surgical complications. Also, from a 
clinical perspective, it may have been interesting to perform a formal 
economic analysis of HBETP. However, based on the COPD literature 
(19), we had no reason to believe that there were major differences in 
realted costs between home-based and in-patient intervention. 
The absence of a control group was another potential limitation 
with regard to interpretation of the results. We elected not to include 
a control group given that one of our main goals was to demonstrate 
the feasibility of the intervention. At this stage, we did not want to 
compromise and slow the progression of the study by trying to include 
a control group. A cross-over study design would have been impossible 
given the imperative surgery schedule. Only a few studies evaluating 
the impact of exercise training in postoperative lung cancer patients 
have included a control group, confirming the challenges associated 
with this methodological design (42,45). 
ConCluSion
In motivated patients under investigation for lung cancer and awaiting 
LRS, an HBETP is a feasible therapeutic modality. Patients showed 
good adherence and were able to achieve the objectives of participa-
tion. In addition, our study found that a four-week HBETP produces 
physiological effects such as improved cycling exercise endurance, 
6MWT distance and muscle strength. Such improvements may be 
clinically relevant because exercise intolerance and muscle weakness 
are predictors of cardiopulmonary complications of thoracic surgical 
procedures.
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